NCT Number: NCT02043444
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT
Compare FDG PET-CT parameters between azoospermia patients having an extraction of sperm cells by positive testicular extraction and those with a negative extraction.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–50 year
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Primary location
UHBordeaux, Bordeaux, France
About this study
One third of infertilities is of exclusive male origin and one third of mixed origin (presence of a male factor). Ten percent of infertile male have azoospermia with a secretory origin in most of cases. Surgical extraction of spermatozoa from testicle is the unique possibility to increase the chance for these men to have children using in vitro fecundation. However, surgical extraction of spermatozoa is successful in 50% of these patients. To date, none of the methods for exploration of male fertility (spermogram, hormonal investigation - with dosage of FSH (follicle stimulating hormone) and inhibin B - and scrotal ultrasound) can predict the success of surgical sperm cells extraction. We also miss the prognostic markers of the testicular function recovery after sterilizing treatments (chemotherapy, radiotherapy). The presence of GLUT3 (glucose) transporters, which are responsible for the fluoro deoxyglucose uptake, has been reported in seminiferous tubules. We have previously shown in a pilot study on a population of men without testis cancer that FDG PET-CT parameters - including the standardized uptake value mean, the standardized uptake value max, and the functional testicular volume - were correlated with the parameters of spermogram (sperm count, motility, vitality). These findings open the way to investigations on the role of the FDG PET-CT in evaluation of secretory azoospermia.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
absence of sperm cells on 2 spermograms in 3 months interval testicular size has to be determined in order to categorized in a group to accept surgery-
Exclusion criteria
allergy to fluoro deoxyglucose clinical varicocele
Treatment and study plan
Primary outcomes
-
measure of standardized uptake value (SUV)
Time frame: 1 month
Secondary outcomes
-
comparison between functional volume with PET exam and volume obtained by scrotal echography
Time frame: 1 month
Other outcomes
-
comparison functional volume with FSH and inhibin
Time frame: 1 month
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
University Hospital, Toulouse
Other
Registry information
Official study title
Comparison of FDG PET-CT Estimated Testis Functional Value Between Patients Having Positive Testicular Sperm Cells Extraction and Patients With a Negative Extraction, in Men With Azoospermia
Acronym: AzoPredHisto
Important dates
- Study start
- 2014
- Primary completion
- 2019
- Study completion
- 2019
- First posted
- Jan 23, 2014
- Registry last updated
- Jan 6, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy
NCT04355312
Adnexal Diseases, Cysts
Clermont-Ferrand, France
View Trial DetailsPresence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?
NCT04487639
COVID-19, Coronaviridae Infections
Reims, France
View Trial DetailsA Clinical Trial to Evaluate the Effects of a Supplement on Markers of Female Fertility
NCT07740187
Female Infertility, Female Urogenital Diseases
Las Vegas, Nevada, United States
View Trial DetailsComparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
NCT06134479
Fertility
Barcelona, Spain
View Trial Details